These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. 1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands. Lee M, Rangisetty JB, Pullagurla MR, Dukat M, Setola V, Roth BL, Glennon RA. Bioorg Med Chem Lett; 2005 Mar 15; 15(6):1707-11. PubMed ID: 15745826 [Abstract] [Full Text] [Related]
44. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents. Leopoldo M, Berardi F, Colabufo NA, Contino M, Lacivita E, Niso M, Perrone R, Tortorella V. J Med Chem; 2004 Dec 16; 47(26):6616-24. PubMed ID: 15588097 [Abstract] [Full Text] [Related]
45. Synthesis and structure-activity relationship (SAR) of (5,7-disubstituted 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidin-2-yl)-methylamines as potent serotonin 5-HT(6) receptor (5-HT(6)R) antagonists. Ivachtchenko AV, Golovina ES, Kadieva MG, Kysil VM, Mitkin OD, Tkachenko SE, Okun IM. J Med Chem; 2011 Dec 08; 54(23):8161-73. PubMed ID: 22029285 [Abstract] [Full Text] [Related]
46. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders. Heal DJ, Smith SL, Fisas A, Codony X, Buschmann H. Pharmacol Ther; 2008 Feb 08; 117(2):207-31. PubMed ID: 18068807 [Abstract] [Full Text] [Related]
47. Novel 2-aminotetralin and 3-aminochroman derivatives as selective serotonin 5-HT7 receptor agonists and antagonists. Holmberg P, Sohn D, Leideborg R, Caldirola P, Zlatoidsky P, Hanson S, Mohell N, Rosqvist S, Nordvall G, Johansson AM, Johansson R. J Med Chem; 2004 Jul 29; 47(16):3927-30. PubMed ID: 15267230 [Abstract] [Full Text] [Related]
48. Design, synthesis and pharmacological evaluation of indolylsulfonamide amines as potent and selective 5-HT6 receptor antagonists. Nirogi RV, Bandyala TR, Reballi V, Konda JB, Daulatabad AV, Khagga M. J Enzyme Inhib Med Chem; 2015 Feb 29; 30(1):85-97. PubMed ID: 24666297 [Abstract] [Full Text] [Related]
54. 5-HT6 receptor antagonists: prospects for the treatment of cognitive disorders including dementia. Johnson CN, Ahmed M, Miller ND. Curr Opin Drug Discov Devel; 2008 Sep 15; 11(5):642-54. PubMed ID: 18729016 [Abstract] [Full Text] [Related]
56. Benzimidazolone-based serotonin 5-HT1A or 5-HT7R ligands: synthesis and biological evaluation. Badarau E, Suzenet F, Bojarski AJ, Fînaru AL, Guillaumet G. Bioorg Med Chem Lett; 2009 Mar 15; 19(6):1600-3. PubMed ID: 19237285 [Abstract] [Full Text] [Related]
57. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding. Metwally KA, Dukat M, Egan CT, Smith C, DuPre A, Gauthier CB, Herrick-Davis K, Teitler M, Glennon RA. J Med Chem; 1998 Dec 03; 41(25):5084-93. PubMed ID: 9836624 [Abstract] [Full Text] [Related]
58. 2,5-Disubstituted pyridines: the discovery of a novel series of 5-HT2A ligands. Wilson KJ, van Niel MB, Cooper L, Bloomfield D, O'Connor D, Fish LR, MacLeod AM. Bioorg Med Chem Lett; 2007 May 01; 17(9):2643-8. PubMed ID: 17314044 [Abstract] [Full Text] [Related]